US Patent 7960161 Alpha-amylase mutants
Patent 7960161 was granted and assigned to Novozymes A/S on June, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 28 Nov, 2023
Golden AI
Edits made to:
Article (+439 characters)
Article
Patent abstract
The invention relates to a variant of a parent Termamyl-like alpha-amylase, which variant has alpha-amylase activity and exhibits an alteration in at least one of the following properties relative to the parent alpha-amylase: substrate specificity, substrate binding, substrate cleavage pattern, thermal stability, pH/activity profile, pH/stability profile, stability towards oxidation, Ca2+dependency and specific activity.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Allan Svendsen0
Henrik Bisgaard-Frantzen0
Torben Vedel Borchert0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07960161 Alpha-amylase mutants US Patent 7960161 Alpha-amylase mutants
Infobox
Patent Number
079601610
Patent Number
79601610
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
079601610
Date of Patent
June 14, 2011
0Patent Application Number
118625800
Date Filed
September 27, 2007
0Patent Primary Examiner
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07960161 Alpha-amylase mutants
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07960161
Date of patent
June 14, 2011
Patent application number
11862580
Date Filed
September 27, 2007
Patent primary examiner
Find more entities like US Patent 7960161 Alpha-amylase mutants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
